Rice University has named its inaugural associate provost for digital learning and strategy. Photo via Rice University/Facebook

Rice University is beefing up its digital education efforts with the hiring of an internationally known expert from Duke University.

Shawn Miller is set to join Rice on November 1 in the newly created position of associate provost for digital learning and strategy. Miller’s hiring culminates a nationwide executive search announced in May 2023 and led by C. Fred Higgs III, vice provost for academic affairs.

Rice explains that Miller “will be the key steward of Rice’s digital strategy — leveraging best practices already in place across the university as well as introducing new approaches and collaborations to be scaled.”

Miller comes to Rice from Duke, a North Carolina school where he most recently has been associate vice provost and chief of staff for learning innovation. Miller previously was Duke’s interim associate vice provost for digital education and innovation. And for six years, he directed Duke Learning Innovation, which he co-designed and launched. He began working for Duke in 2006 as an academic technology consultant.

Shawn Miller is set to join Rice on November 1 in the newly created position of associate provost for digital learning and strategy. Photo courtesy of Rice

Earlier, he led creation of the first learning management system for the University of Texas at El Paso. Miller holds bachelor’s and master’s degrees from UTEP.

“I’ve spent the better part of my career helping universities transform and change to better serve their students,” Miller says in a Rice news release. “I look forward to leveraging my skills to empower Rice’s community of scholars, researchers, and learners to transform themselves, their communities, and others through education.”

In the news release, Joshua Kim, director of online programs and strategy at Dartmouth College in New Hampshire, calls Miller “an internationally recognized leader in the digital learning and online education space.”

“His move to a new leadership role at Rice is a very significant development within our education innovation community,” says Kim.

Miller’s accomplishments at Duke include:

  • Setting up a digital publishing platform for learning
  • Shifting thousands of faculty and students from a legacy learning management system to a new digital system
  • Building a partnership with online education provider Coursera

“Shawn is a national leader in digital innovation and has a deep understanding of digital learning as well as proven experience in building a sustainable, long-term strategy for innovation and developing an integrated approach across the university,” says Amy Dittmar, a Rice provost who is executive vice president for academic affairs.

“I am excited to work with Shawn as he leads Rice to enhance digital education for current students,” Dittmar adds, “and look forward to seeing more professionals in Houston and around the world benefit from a Rice education as a result of his efforts.”

Initiatives spearheaded by Miller and other professionals in digital education have gained traction since the onset of the COVID-19 pandemic, which forced Rice and other colleges and universities to accelerate their embrace of virtual learning.

“The growing adoption of digital learning technologies continues to push education into uncharted areas,” according to an article published this March in the research journal Sustainability.

“While teachers must rethink what it means to provide a learning experience,” the article goes on to say, “higher education institutions must match their educational technology solutions to students’ demands. Digital learning is far superior to the conventional classroom paradigm in many ways for both teachers and students.”

The value of the global market for digital education is projected to jump from $1.2 billion in 2018 to $77.23 billion by 2028, driven in part by growing interest among colleges and universities in augmented reality (AR).

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”

Houston startup raises $6M to scale home-based healthcare platform

fresh funding

As healthcare systems race to expand care beyond hospitals and into the home, investors are placing bigger bets on the infrastructure needed to make that shift possible.

This month, Rosarium Health announced it has raised $6 million in seed funding led by Kalos Ventures, with participation from ResilienceVC, Rock Health Capital, Symphonic Capital, Black Tech Nations Ventures and others.

The investment will help the Houston-based startup continue to build its platform, which features a national network of 800-plus clinicians and 3,000-plus contractors to coordinate home accessibility upgrades and modifications for seniors and people living with disabilities.

For founder and CEO Cameron Carter, the company’s mission grew out of firsthand caregiving experiences.

“From my own personal caregiving experiences, I realized that the benefits exist on paper, but not in reality,” Carter said in a news release. “Families are being left to figure out the paperwork and installations all on their own, which shouldn’t be how this works.”

While Medicare Advantage and Medicaid plans have expanded coverage for home-based services and accessibility modifications, the logistics behind delivering those services often remain fragmented.

Rosarium’s platform coordinates the entire process, from clinical assessments and referrals to contractor management, documentation, reimbursement and installation.

“A clinician can document that a home isn’t safe and a plan can approve a benefit, but there’s no one that’s responsible for making sure the work actually gets done,” Carter says. “We built the missing piece.”

The company was founded in 2021 as Rose Health and was a 2023 participant in the Texas Medical Center’s Accelerator for HealthTech program. It has scaled quickly, building a network of more than 800 clinicians and 3,000 contractors across 34 states.

Rosarium is currently in-network for 1.2 million Medicare and Medicaid lives, with projected coverage expected to reach nearly 4 million by the end of the year, according to the release.

“We’re excited to back Cameron because he and the team at Rosarium are building the infrastructure healthcare needs right now to make the home a safe and comfortable place of care,” Kate Ballinger, investor at Kalos Ventures, added in the release.

As part of the recent investment, Ballinger will join Rosarium’s board of directors.

With eyes on the future, Rosarium plans to grow its partnerships with Medicaid and Medicare Advantage plans, including CalViva and Community Health Plan of Imperial Valley, strengthening its presence in California while expanding access to underserved communities.

Additionally, Carter predicts that home-based healthcare will be part of a broader transformation happening across the industry.

“There’s a growing recognition that health outcomes are shaped by what happens in the home,” he said in the release. “The future of healthcare isn’t just treating people after something goes wrong. It’s creating environments that help prevent those problems in the first place.”